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nel expression was analysed by Western blotting.  Results: 
We identified 3 homozygous mutations in  KCNJ10 (p.F75C, 
p.A167V and p.V91fs197X), with mutation p.A167V previous-
ly reported in a compound heterozygous state. Oocytes ex-
pressing wild-type human KCNJ10 showed inwardly recti-
fied currents, which were significantly reduced in all of the 
mutants (p < 0.001). Specific inhibition of KCNJ10  currents 
by Ba 2+ demonstrated a large residual function in p.A167V 
only, which was not compatible with causing disease. How-
ever, co-expression with KCNJ16 abolished function in these 
heteromeric channels almost completely.  Conclusion: This 
study provides an explanation for the pathophysiology of 
the p.A167V KCNJ10 mutation, which had previously not 
been considered pathogenic on its own. These findings pro-
vide evidence for the functional cooper ation of KCNJ10 and 
KCNJ16. Thus, in vitro ascertainment of KCNJ10 function may 
necessitate co-expression with KCNJ16. 
 © 2013 S. Karger AG, Basel 
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 Abstract 
 Background/Aims: Mutations in the inwardly-rectifying K + -
channel KCNJ10/Kir4.1 cause autosomal recessive EAST syn-
drome (epilepsy, ataxia, sensorineural deafness and tubu-
lopathy). KCNJ10 is expressed in the distal convoluted tu-
bule of the kidney, stria vascularis of the inner ear and brain 
glial cells. Patients diagnosed clinically with EAST syndrome 
were genotyped and mutations in KCNJ10 were studied 
functionally.  Methods: Patient DNA was amplified and se-
quenced, and new mutations were identified. Mutant and 
wild-type KCNJ10 constructs were cloned and heterolo-
gously expressed in  Xenopus oocytes. Whole-cell K + currents 
were measured by 2-electrode voltage clamping and chan-
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 Defective renal tubular ion transport leads to distinct 
salt-losing nephropathies, and the study of these diseases 
has revealed important insights into renal physiology  [1] . 
EAST (epilepsy, ataxia, sensorineural deafness and renal 
tubulopathy) syndrome comprises a salt-losing tubulop-
athy similar to Gitelman syndrome with salt-wasting, 
 activation of the renin-angiotensin-aldosterone system, 
hypokalaemic metabolic alkalosis, hypomagnesaemia 
and hypocalciuria, and is caused by loss of function of 
KCNJ10/Kir4.1  [2, 3] . 
 Here, we present 3 (including 2 new) mutations iden-
tified in 4 patients from 3 consanguineous families and 
describe the consequences for KCNJ10 function in the 
oocyte expression system. Our data provide new insights 
into mutant KCNJ10 assembly and function, as one mu-
tation, p.A167V, had been previously described as non-
pathogenic on its own due to its mild effect on KCNJ10-
mediated currents  [4] .
 KCNJ10 functions either as a homotetramer or forms 
heterotetramers with the related channel KCNJ16  [5] . In 
the renal tubule, KCNJ10 localizes to the basolateral 
membrane of distal convoluted tubular epithelial cells 
 [6] , and supplies K + to the basolateral Na + /K + -ATPase 
that powers transcellular electrolyte transport. Hans 
Ussing initially described this mechanism as pump-leak 
coupling  [7] . In the distal convoluted tubule, KCNJ10 
also maintains the driving force for basolateral Cl – exit 
by hyperpolarizing the basolateral membrane, and thus 
favours transcellular reabsorption of Mg 2+  [8] . Con-
sequently, patients with mutations in this gene, and 
 KCNJ10 –/– mice, also show defective handling of electro-
lytes other than sodium  [2] .
 In the ear, KCNJ10 is expressed in the stria vascularis 
which secretes K + into the endolymph  [9] and is required 
to generate the ‘endocochlear potential’ of around +100 
mV, largely attributable to a K + diffusion potential across 
the apical membrane of strial intermediate cells, which is 
essential for hearing  [10] .
 In the brain and eyes, KCNJ10 is expressed in astroglia 
and retinal Müller cells, and helps maintain the ionic en-
vironment of the extracellular space by providing ‘spatial 
buffering’ of K + by siphoning K + from regions of high 
[K + ] o , generated by neuronal repolarisation, to places of 
low [K + ] o such as neighbouring blood vessels  [11] . In-
wardly rectifying K + channels may facilitate the uptake of 
K + into depolarized glial cells  [12, 13] as well as its release 
at sites of lower extracellular potassium  [14] because glial 
cells are electrically coupled.
 KCNJ10 –/– mice show hearing loss, ataxia and pre-
mature death, the latter a consequence of hypomyelin-
ation and degeneration of the spinal cord  [15] , as well 
as changes in Na + , Ca 2+ and Mg 2+ handling.  KCNJ10 –/– 
mice also show a loss of the slow PIII response of the 
light-evoked electroretinogram, which is generated by 
K + fluxes in Müller cells expressing KCNJ10 and 
KCNJ16  [16] . We recently demonstrated similar find-
ings in patients with EAST syndrome  [17] . When 
KCNJ10 is specifically disrupted in astroglia, mice show 
stress-induced seizures and severe ataxia  [18] . Glial cells 
are strongly depolarized, supporting the role of KCNJ10 
in clearing K + from the extracellular space, which has 
recently been shown directly using K + -selective micro-
electrodes  [19] .
 Mutations previously discovered in the coding region 
of  KCNJ10 include the homozygous missense mutations 
p.R65P, p.G77R, p.C140R and p.T164I  [2, 3] . Compound 
heterozygous missense/nonsense mutations p.R65P and 
p.R199X and compound heterozygous missense muta-
tions p.A167V and p.R297C were found in two other kin-
dreds  [3] .  Table 1 compiles all functionally characterized 
mutations in  KCNJ10 published so far.
 The comparative effects of some  KCNJ10 mutations 
were analysed at the whole-cell level and replicated at the 
single-channel level, with strongly reduced open proba-
bility in R65P and R175Q and almost absent channel ac-
tivity in G77R  [20] . Excised patches showed a dramatic 
shift of the pH sensitivity in the mutant channels R65P 
and R175Q, with some residual channel activity at un-
physiologically high pH. A study of heterologously ex-
pressed mutant channels found less residual conductance 
when intracellular pH was reduced from 7.4 to 6.8, which 
showed a minimal effect on wild-type (WT) KCNJ10  [4] . 
Due to undetectable currents, the truncated KCNJ10 
R199X could not be investigated in isolation  [20] . We 
 recently investigated 3 partially functional mutations: 
p.R65C (c.193C>T) identified in 1 patient, a homozygous 
missense mutation p.F75L (c.225T>G) identified in 2 af-
fected siblings and a homozygous missense mutation 
p.R297C (c.889C>T) identified in 1 patient  [21] . A frame-
shift mutation p.V259fs259X resulted in complete loss of 
function  [21] .
 We now describe further mutations found in patients 
clinically diagnosed with EAST syndrome. The muta-
tions were cloned and heterologously expressed in  Xeno-
pus laevis oocytes to investigate the function of mutant 
KCNJ10 by 2-electrode voltage clamping.





 Materials and Methods 
 Genomic DNA Sequencing 
 Genetic studies were approved by the Institute of Child Health-
Great Ormond Street Hospital Research Ethics Committee, after 
obtaining written consent. The entire single coding exon and ad-
jacent intronic sequence of  KCNJ10 was sequenced by the Sanger 
method using a Beckman Coulter CEQ8000 or an ABI prism 377 
sequencer. PCR primer sequences can be supplied on request. En-
sembl gene transcript ENST00000368089 was used as a reference.
 Cloning of Mutant KCNJ10 
 Mutant KCNJ10 was inserted into the pTLB oocyte expression 
vector after PCR amplification of the single coding exon with 
primers introducing Xho I and Xba I restriction sites, maintaining 
the Kozak sequence  [22] , using Phusion polymerase (NEB, UK). 
Ligated plasmids were transformed into  Escherichia coli XL1 blue 
(Stratagene, USA), and plasmid DNA was purified using Nu-
cleoSpin ® columns (Macherey-Nagel, Düren, Germany) follow-
ing the manufacturer’s recommendations. cDNA inserts of all 
plasmids were fully sequence verified.
 Heterologous Expression of KCNJ10 
 Plasmids containing mutant and WT KCNJ10  [2] were linear-
ized by Mlu I digestion (Fermentas, UK), and cRNA was synthe-
sized using the mMESSAGE mMACHINE ® SP6 Kit (Ambion, 
UK).  Adult female  Xenopus laevis (University of Portsmouth) were 
sacrificed under Home Office-licensed Schedule 1 of the Animals 
(Scientific Procedures) Act 1986, and the ovaries were dissected 
and digested with collagenase (Type II, Invitrogen) dissolved at 
1–2 mg/ml in ND96, containing (in m M ): 96 NaCl, 2 KCl, 1.8 
CaCl 2     ·     2H 2 O, 1 MgCl 2     ·     6H 2 O, 5 HEPES and pH 7.5 (NaOH). 
Healthy-looking stage V and VI oocytes  [23] were selected for in-
jection with 1–2 ng WT or mutant KCNJ10 cRNA and then incu-
bated for 1–2 days at 17  °  C.
 Western Blotting 
 Membrane fractions were extracted by trituration and 2 cen-
trifugation steps at 4,000  g for 3 min to remove yolk and lipids 
from 10 oocytes each, and then injected with mutant, WT or con-
trol. The intermediate phase was denatured in SDS-containing 
loading buffer and run on 8.5 or 10% polyacrylamide gels. Proteins 
were transferred to a PVDF membrane (Trans-Blot Turbo pack,
BioRad, UK) using a semidry blotter (BioRad, UK). Membranes 
were stained with 0.2% Ponceau’s stain in 5% acetic acid for 5 min, 
washed and imaged. The membrane was blocked and incubated 
with the KCNJ10 monoclonal antibody 1C11 (Sigma, UK) or a 
polyclonal antibody against KCNJ16  [20] . Bound primary anti-
bodies were detected by secondary anti-mouse or anti-rabbit anti-
bodies coupled to peroxidase and enhanced chemiluminescence 
using home-made reagents and imaged using a Dyversity gel anal-
yser and Genesnap software (Syngene, UK).
 Voltage Clamping 
 Voltage clamping was performed with a TEC01C amplifier 
(NPI Electronic GmbH, Tamm, Germany). Oocytes were perfused 
with ND96 with 18 m M KCl added (in order to increase specific 
currents as Kir channel conductance increases with [E K+ ] o  [22, 23] ) 
in an RC-1Z Oocyte Chamber (Harvard Apparatus, UK). Micro-
electrodes were pulled from 1.5-mm glass capillaries with filament 
(Harvard Apparatus) using a DMZ-universal puller (Zeitz, Augs-
burg, Germany), and had a resistance of <1 MΩ when filled with 
3  M KCl. Recordings were controlled using Strathclyde WinWCP 
and a PCI-6251 interface (National Instruments, UK), pro-
grammed at clamp steps from +100 to –100 mV in 20 mV decre-
ments, each lasting 500 ms. The baseline holding voltage was held 
at –40 mV, close to E K+ . 100 μ M BaCl 2 was used as a reversible spe-
cific inhibitor of inwardly rectifying K + channels  [24] . Recordings 
were analysed and plotted using Strathclyde electrophysiology 
software (written and supported by John Dempster, Strathclyde 
University, UK) and Origin (OriginLab, Northampton, Mass., 
USA).




effect in mammalian cells
Surface expression Refs. Origin
p.T57I loss of function at surface [35] Somalian
p.R65C ~20% function [21] Algerian
p.R65P ~20% function partially functional at surface [2, 4, 20] Pakistani
p.F75L <10% function [21] Afro-Caribbean
p.G77R <5% function partially functional at surface, but reduced [2, 4, 20] UAE
p.C140R loss of function at surface, but reduced [4, 30] ?
p.T164I loss of function at surface [4, 30] ?
p.A167V ~65% function ~65% function at surface, but reduced [4, 30] Italian/Dutch
(Turkish origin)
p.R175Q <5% function at surface [20] Iranian
p.R199X loss of function loss of surface expression




p.V259X loss of function [21] Indian
p.R297C <10% function ~5% function at surface [4, 21, 30] Iranian





 Statistical Analysis 
 Statistical analysis was performed using Origin. One-sided and 
two-sided Student’s t tests were used as appropriate for paired and 
unpaired data, and p < 0.05 was considered significant. All data are 
given as means ± SEM.
 Results 
 We identified 2 new mutations, p.F75C and 
p.V91fs197X (p.V91Gfs197X, due to a c.272delT muta-
tion at cRNA level), and a known mutation p.A167V  [4] 
in 4 consanguineous families. As expected, individuals af-
fected with EAST syndrome showed homozygous muta-
tions. Interestingly, the p.A167V, previously reported to 
be disease-causing only when paired with another more 
severe mutation, was also found to be homozygous, and 
no other mutations were detected in the entire coding se-
quence and adjacent splice sites. We therefore studied 
this mutation in more detail.
 As a first screen, we expressed all mutant channels 
along with water and WT controls in  Xenopus oocytes. 
Currents in oocytes expressing KCNJ10 F75C and 
 V91fs197X were indistinguishable from endogenous cur-
rents observed in water-injected oocytes ( fig. 1 a). As de-
scribed previously  [4] , KCNJ10 A167V led to a mild re-
duction in current as compared to WT (to approx. 60%). 
This is also clearly seen in the analysis of chord conduc-
tances (–100; 0 mV) depicted in  figure 1 b. In a separate 
batch of oocytes, we analysed the barium block of these 
conductances ( fig. 1 c). Although there is a trend for some 
current remaining with submaximal barium (100 μ M , 















































WT (n = 7)
Water (n = 4)
F75C (n = 5)
V91fs197X (n = 5)
A167V (n = 6)
 Fig. 1.  a Averaged current/voltage curves obtained in  Xenopus oo-
cytes injected with 2 ng WT or mutant KCNJ10 cRNA. Oocytes 
expressing KCNJ10 F75C and V91fs197X are indistinguishable 
from water-injected oocytes. Oocytes were held in 20 m M K + at –40 
mV and clamped from +100 to –100 mV in 20 mV steps. Note that 
currents reversed around –40 mV due to the 20-m M K + solution 
used. Three batches of oocytes were analysed.  b Analysis of the 
chord conductance between –100 and 0 mV.  c Barium (100 μ M ) 
inhibited more strongly the inward component of WT and A167V 
mutant currents. 





with 20 m M K + ) in KCNJ10 F75C and V91fs197X, only 
WT and A167V-expressing oocytes showed significant 
block in the negative voltage range, as expected for a pore 
blocker.
 EAST syndrome in a patient with a homozygous muta-
tion exhibiting 60% residual function poses a genetic di-
lemma (parents heterozygous for p.F75C or p.V91fs197X 
would be expected to have an even greater degree of func-
tional impairment, yet are asymptomatic). KCNJ10 either 
forms homotetramers or heterotetramers with the related 
channel KCNJ16  [5] . We therefore studied heteromeric 
KCNJ10/KCNJ16 channels. Co-expression of an excess 





WT (n = 14)
F75C (n = 13)
V91fs197X (n = 17)






























 Fig. 2.  a Averaged current/voltage curves obtained in  Xenopus oo-
cytes injected with 2 ng WT or mutant KCNJ10 cRNA and 4 ng 
KCNJ16 cRNA. Note the more pronounced inward rectification in 
WT KCNJ10/16 heteromeric channels (‘WT’ in the figure). 
KCNJ10 A167V/KCNJ16 (‘A167V’) showed current significantly 
different from the 2 non-functional mutations (‘F75C’ and 
 ‘V91fs197X’), but these currents were so low that currents from all 
mutations virtually superimpose.  b Analysis of the chord conduc-
tance between –100 and 0 mV. Conductances as a percentage of 
WT KCNJ10: A167V, 1.7%; F75C, 0.7%; V91fs197X, 0.7%. The 
latter 2 are consistent with conductances endogenous to the oo-
cyte. 
WT + J16 (n = 20)
WT (n = 21)
A167V (n = 13)


































A167V + J16A167VWT WT + J16
 Fig. 3.  a Averaged current/voltage curves obtained in  Xenopus oo-
cytes expressing WT and KCNJ10 A167V (1 ng) with and without 
KCNJ16 (3 ng) in the same batch of oocytes. Again, altered recti-
fication for WT and almost complete loss of current for KCNJ10 
A167V upon co-expression with KCNJ16 was observed.  b Analysis 
of the chord conductance between –100 and 0 mV. Conductances 
as a percentage of WT KCNJ10 alone: KCNJ10/KCNJ16, 64%; 
KCNJ10 A167V alone, 58%; KCNJ10 A167V/KCNJ16, 0.8%. 





of KCNJ16 cRNA resulted in currents with much stron-
ger inward rectification for WT and failed to rescue F75C 
and V91fs197X mutant KCNJ10. Interestingly, currents 
were almost completely abolished in oocytes expressing 
KCNJ10 A167V/KCNJ16 heteromeric channels ( fig. 2 a). 
Less than 2% of the current remained, as is more clearly 
seen in the analysis of chord conductances ( fig. 2 b).
 We next confirmed the effect of KCNJ16 co-expres-
sion on KCNJ10 A167V in the same batch of oocytes. 
These results are summarized in  figure 3 . Whereas co-
expression of KCNJ16 with WT KCNJ10 (injected at 3: 1 
cRNA stoichiometry) merely altered rectification, it al-
most completely abolished currents in oocytes expressing 
KCNJ10 A167V/KCNJ16 heteromeric channels ( fig. 3 a). 
This is clearly reflected in the chord conductance analysis 
shown in  figure 3 b.
 The next experiments addressed the stability of mu-
tant KCNJ10. The expression level of KCNJ10 was similar 
in oocytes injected with WT and mutant KCNJ10 cRNA 
( fig. 4 a), except for KCNJ10 V91fs197X in which the epi-
tope is absent and the channel can therefore not be de-
tected by our antibody. In order to assess the relative time 
course of expression for KCNJ10 and KCNJ16, we first 
analysed expression level at 18, 24, 36 and 48 h. Both 
channels appear to peak around 36 h ( fig. 4 a, KCNJ10; 
 fig. 4 b, KCNJ16). Note that the band in  figure 4 b running 
at approximately 35 kDa and present in all samples is 
non-specific (also present in water-injected oocytes) and 
indicates equal loading of all lanes. Co-expression of 
KCNJ16 ( fig. 4 e) with KCNJ10 A167V at two different 
time points did not affect overall stability of KCNJ10 
A167V ( fig.  4 d, same blot as in e, but reprobed for 
KCNJ10). Note that the band present in all samples in 
 figure 4 e is non-specific and indicates equal loading.
 Discussion 
 Bartter’s syndromes result from mutations in trans-
porters and ion channels in the loop of Henle, which 
function in a concerted fashion. More distally, the gener-
ally milder Gitelman syndrome results from mutations 
in the NaCl cotransporter mainly expressed in the distal 
convoluted tubule  [25] , and pseudohypoaldosteronism 
can result from mutations in the epithelial sodium chan-
nel  [26] . Loss of KCNJ10/Kir4.1 causes an autosomal re-
cessive salt-losing renal tubulopathy similar to Gitelman 
syndrome with salt-wasting, activation of the renin-an-
giotensin-aldosterone system, hypokalaemic metabolic 
alkalosis, hypomagnesaemia and hypocalciuria  [2, 3] . In 
b
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18 h 24 h 36 h 48 h
M
 Fig. 4.  a KCNJ10 WT, A167V, F75C and V91fs197X expressed in 
oocytes, separated by SDS-PAGE and probed for KCNJ10. Note 
that V91fs197X cannot be detected with our antibody as it recog-
nizes an epitope lost through frameshift in this mutation, suggest-
ing the antibody is specific.  b ,  c Time-course of expression of 1 ng 
KCNJ10 and 3 ng KCNJ16 cRNA co-expressed in oocytes over 
48 h. Detection in membrane preparations with a monoclonal an-
tibody against KCNJ10 ( b ), and with a polyclonal antibody against 
KCNJ16 ( c ).  d Western blot probed for KCNJ10 prepared from 
oocytes expressing KCNJ10 A167V with and without KCNJ16. 
 e Same membrane as in  d , probed for KCNJ16. Expression levels 
appear somewhat lower for KCNJ10 A167V, but the co-expression 
with KCNJ16 does not alter expression significantly, suggesting 
that overall stability of KCNJ10 A167V is unaltered by hetero-
merisation with KCNJ16. KCNJ10 is known to produce multiple 
bands on Western blotting, depending on the preparation  [34] . 
Note that the lane description applies for  d and  e . Arrows indicate 
specific bands throughout the figure, and M indicates molecular 
weight marker lanes with the approximate molecular weight given 
in kDa. 





mice, there is also expression of KCNJ10 in the connect-
ing tubule, and in the cortical collecting duct. In humans 
there may also be expression in the cortical thick ascend-
ing limb of the loop of Henle  [27, 28] . In addition to these 
renal tubule segments, KCNJ10 is also expressed in the 
brain, inner ear and eyes, and mutations in this channel 
can lead to EAST syndrome  [2] .
 Multiple pathogenic  KCNJ10 mutations have been 
previously described in patients with EAST syndrome. 
Some mutations have residual function (p.A167V> 
p.R65P>p.R175Q>p.G77R)  [2, 21] , as summarized in 
 table 1 . p.R199X, a nonsense mutation, displayed com-
plete loss of function  [4] , but was only identified in a com-
pound heterozygous patient.
 We previously described mutations with severely im-
paired function (p.R297C seen for the first time in a ho-
mozygous state, and 3 new mutations: p.R65C, p.F75L, 
p.V259X)  [21] . Three of these mutated channels had re-
sidual function (R65C>F75L>R297C)  [21] .
 In the present study, we describe a p.F75C substitu-
tion, which, consistent with a less conservative exchange 
compared to p.F75L, led to a complete loss of function. 
The results were very similar for the early frameshift mu-
tation p.V91fs197X. We cannot exclude residual function 
at 1–2% of WT levels, due to limitations of the expression 
system. However, it is questionable whether less than 2% 
residual function would be physiologically relevant. 
 We confirmed strong residual function in KCNJ10 
A167V, a mutation which has been described previously 
 [4, 29, 30] . Based on genetic evidence available at the time, 
it was hypothesized that this mutation could only cause 
disease when paired with a functionally more severe mu-
tation  [29, 30] . However, we now found this mutation in 
a homozygous state in 3 patients with EAST syndrome, 
although no epileptic seizures have been described in 2 
patients from one family. Infrequent epileptic episodes 
can be overlooked, so at this point it is unclear whether 
these patients have genuine absence of epilepsy, or wheth-
er it has not been recognized. The patients do show hy-
pokalaemic alkalosis, hypomagnesaemia, sensorineural 
hearing loss and ataxia, which are hallmarks of EAST syn-
drome in all 3 affected organ systems. As the parents of 
patients with loss-of-function mutations are asymptom-
atic, we were initially puzzled by this finding, as KCNJ10 
A167V alone shows >60% of WT function. KCNJ10 
has been reported to form heteromeric channels with 
KCNJ16 both in expression systems  [5] , native astrocytes 
 [31] and the kidney distal convoluted tubule  [27, 32] . 
KCNJ16 does not mediate currents on its own, but in-
creases inward rectification in KCNJ10/KCNJ16 hetero-
meric channels  [5] . We therefore hypothesized that 
KCNJ16 co-expression might reduce function of KCNJ10 
A167V. Indeed, we found a very strong reduction of cur-
rents in KCNJ10 A167V/KCNJ16 heteromeric channels. 
This provides a rationale for how brain and kidney phe-
notypes could develop – in the absence of strong func-
tional defects of homomeric KCNJ10 A167V. Although 
decreased surface expression has been described for this 
mutation  [29, 30] , this effect was much weaker than what 
we would expect from our functional data on heteromer-
ic channels. As overall expression was unchanged, and 
not affected by KCNJ16 co-expression, we hypothesize 
that heteromeric channels are less likely to traffic to the 
surface.
 Interestingly, although KCNJ16 is expressed in the in-
ner ear, it has not been shown to be expressed in strial 
intermediate cells, where KCNJ10 resides in the apical 
membrane and generates the strong positive endocochle-
ar potential essential for the hearing process  [9, 10] . The 
endocochlear potential, together with the high K + con-
centration present in the endolymph, makes K + enter co-
chlear hair cells through mechanosensitive channels. 
KCNJ16 is rather expressed in cochlear wall fibrocytes 
 [33] . We do not have a satisfactory explanation for the 
hearing loss observed in patients with a homozygous 
p.A167V mutation. However, we speculate that co-ex-
pression of other channels present in these cells may have 
a similar effect as co-expression of KCNJ16 described 
here.
 In summary, we describe 2 new mutations in KCNJ10, 
both of which lead to loss of function, within the resolu-
tion of our technique. We also provide an explanation for 
the pathogenicity of KCNJ10 mutation p.A167V, which 
has previously been thought to be a disease modifier in 
the context of another, more severe mutation.
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